Literature DB >> 11325894

Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL.

A Kondo1, Y Muranaka, I Ohta, K Notsu, M Manabe, K Kotani, K Saito, M Maekawa, T Kanno.   

Abstract

BACKGROUND: Hypertriglyceridemia is associated with decreased HDL-cholesterol (HDL-C) and increased small dense LDL. In addition, small dense LDL is known to be susceptible to oxidation.
METHODS: We measured LDL particle size, using gradient gel electrophoresis, and malondialdehyde-modified LDL (MDA-LDL), using an ELISA, and investigated the association between triglyceride (TG) concentrations, LDL size, and MDA-LDL.
RESULTS: TG concentrations correlated negatively with the predominant LDL size (r = -0.650) and HDL-C concentration (r = -0.556). The relationship between TG concentration and LDL size, evaluated by measuring MDA-LDL, distinguished subgroups derived from four subfractions of TG concentrations and four distribution ranges of LDL size. These experiments indicated that there is a threshold for oxidation susceptibility at an LDL size of 25.5 nm and a TG concentration of 1500 mg/L. To investigate the relationship between LDL size, MDA-LDL concentration, and other lipids (TGs, HDL-C, apolipoprotein B, and total cholesterol), we evaluated them in control subjects and patients with diabetes mellitus or hypertriglyceridemia. When the size range for normal LDL was postulated to be 25.5 < or = phi (LDL diameter) < 26.5 nm, the MDA-LDL concentration was significantly higher in the subgroups of patients with LDL in the size range 24.5 < or = phi < 25.5 nm compared with patients with normal LDL. This result also suggests that the threshold is at a LDL size of 25.5 nm.
CONCLUSION: The threshold for oxidation susceptibility coincided with the point of LDL size separation between the LDL subclass patterns A and B as an atherosclerotic risk.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325894

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study.

Authors:  Giovanni Zuliani; Mario Luca Morieri; Stefano Volpato; Giovanni B Vigna; Cristina Bosi; Marcello Maggio; Antonio Cherubini; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2012-10-11       Impact factor: 5.162

2.  Alpha lipoic Acid prevents pancreatic islet cells damage and dyslipidemia in streptozotocin-induced diabetic rats.

Authors:  Siti Balkis Budin; Kwa Poi Kee; Monica Yau Swee Eng; Khairul Osman; Mokhtar Abu Bakar; Jamaludin Mohamed
Journal:  Malays J Med Sci       Date:  2007-07

Review 3.  Fenofibrate and Dyslipidemia: Still a Place in Therapy?

Authors:  Nicola Tarantino; Francesco Santoro; Michele Correale; Luisa De Gennaro; Silvio Romano; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

4.  Associations of lipoprotein subclasses and oxidative stress status in pulmonary and pulmonary plus extrapulmonary sarcoidosis.

Authors:  Jasmina Ivaniševic; Jelena Vekic; Aleksandra Zeljkovic; Aleksandra Stefanovic; Jelena Kotur-Stevuljevic; Vesna Spasojevic-Kalimanovska; Slavica Spasic; Violeta Vucinic-Mihailovic; Jelica Videnovic-Ivanov; Zorana Jelic-Ivanovic
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 5.  Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs.

Authors:  Simi Gunaseelan; Krishnan Gunaseelan; Manjeet Deshmukh; Xiaoping Zhang; Patrick J Sinko
Journal:  Adv Drug Deliv Rev       Date:  2009-11-24       Impact factor: 15.470

6.  Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice.

Authors:  Xinmei Zhu; Hang Pong Ng; Yen-Chun Lai; Jodi K Craigo; Pruthvi S Nagilla; Pooja Raghani; Shanmugam Nagarajan
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

7.  Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study.

Authors:  Kazuo Ogawa; Toshikazu Tanaka; Tomohisa Nagoshi; Hiroshi Sekiyama; Satoshi Arase; Kosuke Minai; Takayuki Ogawa; Michihiro Yoshimura
Journal:  BMJ Open       Date:  2015-01-21       Impact factor: 2.692

8.  Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients.

Authors:  Masami Tanaka; Risa Nishimura; Takeshi Nishimura; Toshihide Kawai; Shu Meguro; Junichiro Irie; Yoshifumi Saisho; Hiroshi Itoh
Journal:  Diabetol Metab Syndr       Date:  2014-05-18       Impact factor: 3.320

9.  Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits.

Authors:  Paula R Augusti; Andréia Quatrin; Sabrina Somacal; Greicy Mm Conterato; Rocheli Sobieski; Amanda R Ruviaro; Luana H Maurer; Marta Mf Duarte; Miguel Roehrs; Tatiana Emanuelli
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

10.  Reduced Antioxidant Potential of LDL Is Associated With Increased Susceptibility to LDL Peroxidation in Type II Diabetic Patients.

Authors:  Nivedita Singh; Neelima Singh; Sanjeev Kumar Singh; Ajay Kumar Singh; Deepak Kafle; Navneet Agrawal
Journal:  Int J Endocrinol Metab       Date:  2012-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.